Uric Acid and Kidney

  • Giorgio Fuiano
  • Stefano Federico
  • Giuseppe Conte
  • Vittorio E. Andreucci
Part of the Advances in Experimental Medicine and Biology book series (AEMB, volume 252)


Uric acid is the end product of purine metabolism in humans. In animals other than mammals uric acid undergoes further degradation because of the activity of enzymes such as uricase, allantoinase and allantoinase; in some species the urea that is formed is further hydrolyzed to ammonia and CO2 by the urease of intestinal bacteria (1).


Uric Acid Calcium Oxalate Uric Acid Stone Monosodium Urate Urinary Uric Acid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    N.A. Breslau and K. Sakhaee, Pathophysiology of nonhypercalciuric causes of stones. in: “Renal Stone Disease”, C.Y.C. Pak, ed., Martinus Nijhoff Publishing, Boston (1987), pp. 47–84.CrossRefGoogle Scholar
  2. 2.
    E.W. Holmes, Uric acid nephrolithiasis, in: “Nephrolithiasis”, F.L. Coe, ed., Churchill Livingstone, New York (1972), pp. 325–336.Google Scholar
  3. 3.
    L.B. Sorensen, Role of the intestinal tract in the elimination of uric acid, Arth. Rheum. 8: 994 (1965).CrossRefGoogle Scholar
  4. 4.
    L.B. Sorensen, Extrarenal disposal of uric acid. in: “Uric acid”, W.N. Kelley and I.N. Weiner, eds., Springer-Verlag, New York (1978), pp. 325–336.CrossRefGoogle Scholar
  5. 5.
    A. Atsmon, A. DeVries and M. Frank, “Uric Acid Lithiasis”, Elsevier, Amsterdam (1963).Google Scholar
  6. 6.
    A. Bollinger and R. Gross, Ammonia, urea and uric acid content of toe nails in renal insufficiency and gout, Aust. Exp . Biol. Med. Sci. 31: 385 (1953).CrossRefGoogle Scholar
  7. 7.
    V.E. Andreucci, “Acute Renal Failure”, Martinus Nijhoff Publishing, Boston (1984).CrossRefGoogle Scholar
  8. 8.
    J.D. Conger, S.A. Falk, S.J. Guggenheim and T.J. Burke, A micropuncture study of the early phase of acute urate nephropathy, J. Clint Invest. 58: 681 (1976).CrossRefGoogle Scholar
  9. 9.
    J.D. Conger and S.A. Falk, Intrarenal dynamics in the pathogenesis and prevention of acute urate nephropathy, J. Clin. Invest. 59: 786 (1977).PubMedCrossRefGoogle Scholar
  10. 10.
    R.E. Rieselbach, C.J. Benzel, E. Cotlove, E. Frei and E.J. Freireich, Uric acid excretion and renal function in the acute hyperuricemia of leukemia. Am. J. Med. 37: 872 (1964).PubMedCrossRefGoogle Scholar
  11. 11.
    J. Kelton, W.N. Kelley and E.W. Holmes, A rapid method for the diagnosis of acute uric acid nephropathy. Arch. Intern. Med. 138: 612 (1978).PubMedCrossRefGoogle Scholar
  12. 12.
    B. Finlayson and A. Smith, Stability of first dissociable proton of uric acid, J. Chem. Eng. Data, 19: 94 (1974).CrossRefGoogle Scholar
  13. 13.
    F.L. Coe, A.L. Stauss, V. Tembe and M.S.L. Dunn, Uric acid saturation in calcium nephrolithiasis, Kidnev Int. 17: 661 (1980).Google Scholar
  14. 14.
    C.Y.C. Pak, N.A. Breslau and J.A. Harvey, Nutrition and metabolic bone disease, in: “Nutritional Diseases: Research Directors in Comparative Pathobiology”, D.G. Scarpelli and G. Migaki, eds., Alan R. Liss, New York (1986) pp 115–140.Google Scholar
  15. 15.
    C.Y.C. Pak, “Renal Stone Disease”, Martinus Nijhoff Publishing, Boston (1987).CrossRefGoogle Scholar
  16. 16.
    C.Y.C. Pak, D.E. Barilla, K. Holt, L. Brinkley, R. Tolentino and J.E. Zerwekh, Effect of oral purine load and allopurinol on the crystallization of calcium salts in urine of patients with hyperuricosuric calcium urolithiasis. Am. J. Med. 65: 593 (1978).PubMedCrossRefGoogle Scholar
  17. 17.
    F.L. Coe and A.G. Kavalach, Hypercalciuria and hyperuricosuria in patients with calcium nephrolithiasis, N. Eng. J. Med. 291: 1344 (1974).CrossRefGoogle Scholar
  18. 18.
    C.Y.C. Pak, O. Waters, L. Arnold, K. Holt, C. Cox and D.E. Barilla, Mechanism of calcium urolithiasis among patients with hyperuricosuria: supersaturation of urine with respect to monosodium urate, J. Clin. Invest. 59: 426 (1977).PubMedCrossRefGoogle Scholar
  19. 19.
    C.Y.C. Pak and L. Arnold, Heterogeneous nucleation of calcium oxalate by seeds of monosodium urate, Proc. Soc. Exp . Biol. Med. 149: 930 (1975).PubMedGoogle Scholar
  20. 20.
    F.L. Coe, R.L. Lawton, R.B. Goldstein and V. Tembe, Sodium urate accelerates precipitation of calcium oxalate in vitro, Proc. Soc. Exp. Biol. Med. 149: 926 (1975).PubMedGoogle Scholar
  21. 21.
    C.Y.C. Pak, K. Holt and J.E. Zerwekh, Attenuation by monosodium urate of the inhinitory effect of mucopolysaccharide on calcium oxalate nucleation. Invest. Urol. 17: 138 (1979).PubMedGoogle Scholar
  22. 22.
    C.M. Kjellstrand, D.C.H. Campbell, B. von Hartitzsch and T.J. Bus1meier, Hyperuricemic acute renal failure, Arch. Intern. Med. 133: 349 (1974).PubMedCrossRefGoogle Scholar
  23. 23.
    J.O. Wool Iiscroft, H. Colfer and I.H. Fox, Hyperuricemia in acute illness: a poor prognostic sign, Am. J. Med. 72: 58 (1982).CrossRefGoogle Scholar
  24. 24.
    L.H. Beck, Requiem for gouty nephropathy, Kidnev Int., 30: 280 (1986).CrossRefGoogle Scholar
  25. 25.
    J.M. Charcot, Clinical lectures on senile and chronic diseases. Translated by W.S. Tuke, The New Sydenham Society, London (1881).Google Scholar
  26. 26.
    R.P. Wedeen and V. Batuman, Tubulo-interstitial nephritis induced by heavy metals and metabolic disturbances, in: “Tubulo-interstitial nephropathies”, R.S. Cotran, ed., Churchill Livingstone, New York (1983) pp. 211–241.Google Scholar
  27. 27.
    W.J. Fessel, Renal outcomes of gout and hyperuricemia. Am. J. Med. 67: 74 (1979).PubMedCrossRefGoogle Scholar
  28. 28.
    T.F. Yu, T.L. Berger, D.J. Dorph and H. Smith, Renal function in gout. V. Factors influencing the renal hemodynamics. Am. J. Med. 67: 766 (1979).PubMedCrossRefGoogle Scholar
  29. 29.
    T.F. Yu and T.L. Berger, Renal disease in primary gout: a study of 259 gout patients with proteinuria, Semin. Arthritis Rheum., 4: 293 (1975).PubMedCrossRefGoogle Scholar
  30. 30.
    T.L. Berger and T.F. Yu, Renal function in gout. IV. An analysis of 524 gouty subjects including long-term follow-up studies. Am. J. Med. 59: 605 (1975).PubMedCrossRefGoogle Scholar
  31. 31.
    T.F. Yu and T.L. Berger, “The kidney in gout and hyperuricemia”, Futura Publishing, Mount Kisco, NY (1982).Google Scholar
  32. 32.
    R.L. Wortmann and I.H. Fox, Limited value of uric acid to creatinine ratios in estimating uric acid excretion, Ann. Intern. Med. 93: 822 (1980).PubMedGoogle Scholar
  33. 33.
    C.Y.C. Pak, Prevention of recurrent nephrolithiasis, in: “Renal Stone Disease”, C.Y.C. Pak, ed., Martinus Nijhoff Publishing, Boston (1987).CrossRefGoogle Scholar
  34. 34.
    N.A. Breslau, K. Sakhaee, C. Crowther and L. Brinkley, Evidence justifying a high fluid intake in treatment of nephrolithiasis, Ann. Intern, Med. 93: 36 (1981).Google Scholar
  35. 35.
    C.Y.C. Pak and R. Peterson, Successful treatment of hyperuricosuric calcium oxalate nephrolithiasis with potassium citrate, Arch. Intern. Med. 146: 863 (1986).PubMedCrossRefGoogle Scholar

Copyright information

© Plenum Press, New York 1989

Authors and Affiliations

  • Giorgio Fuiano
    • 1
  • Stefano Federico
    • 1
  • Giuseppe Conte
    • 1
  • Vittorio E. Andreucci
    • 1
  1. 1.Department of Nephrology, Second Faculty of MedicineUniversity of NaplesNaplesItaly

Personalised recommendations